Description
Cefepime & Tazobactam for Injection
Ristopime-T Injection is a sterile combination of Cefepime and Tazobactam, formulated for the treatment of moderate to severe bacterial infections caused by susceptible microorganisms. Cefepime is a fourth-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis, while Tazobactam is a beta-lactamase inhibitor that protects Cefepime from enzymatic degradation by beta-lactamase-producing bacteria, thereby extending its antibacterial spectrum and enhancing its clinical effectiveness.
This combination provides broad-spectrum antibacterial coverage against a wide range of Gram-positive and Gram-negative bacteria and is commonly used in the management of respiratory tract infections, urinary tract infections, intra-abdominal infections, skin and soft tissue infections, bloodstream infections, and febrile neutropenia. The injectable formulation offers rapid systemic action and should be administered only under the supervision of a qualified healthcare professional.
Key Benefits
- Broad-spectrum fourth-generation cephalosporin antibiotic.
- Enhanced efficacy against beta-lactamase-producing bacteria.
- Effective in managing moderate to severe bacterial infections.
- Suitable for intravenous and intramuscular administration.
- Rapid systemic antibacterial action.
- Helps treat infections caused by susceptible Gram-positive and Gram-negative organisms.
- Intended for use under medical supervision.
Composition
Each vial contains:
- Cefepime IP equivalent to 500 mg
- Tazobactam Sodium IP equivalent to 62.5 mg
Total Strength: 562.5 mg
Indications
Recommended for the treatment of susceptible bacterial infections, including:
- Lower and upper respiratory tract infections
- Urinary tract infections
- Skin and soft tissue infections
- Intra-abdominal infections
- Bloodstream infections (Septicemia)
- Febrile neutropenia
- Complicated bacterial infections requiring broad-spectrum antibiotic therapy
Directions for Use
Reconstitute the vial with the recommended sterile diluent before administration. Administer only by I.V. or I.M. injection under the supervision of a qualified healthcare professional. The dosage and duration of therapy should be determined by the treating physician based on the patient’s age, body weight, severity of infection, and renal function.
Storage
- Store below 25°C in a cool and dry place.
- Protect from light and moisture.
- Use the reconstituted solution within the recommended time.
- Keep out of reach of children.
Reviews
There are no reviews yet.